DuPont de Nemours Inc. (NYSE:DD) shares traded lower Tuesday after the company reported second-quarter 2026 results that beat analyst expectations and raised its full-year earnings outlook, as investors weighed the updated forecast.
Despite the quarterly beat, shares traded lower as investors assessed the narrowed sales outlook and currency headwinds alongside the improved earnings forecast.
Earnings And Margins
Adjusted EPS rose 48% to $1.88, beating the $1.76 estimate. Net sales increased 4% year over year to $1.819 billion, above the $1.813 billion estimate, while organic sales also grew 4%.
GAAP diluted EPS from continuing operations increased to $1.37 from 17 cents. GAAP income from continuing operations rose to $191 million from $24 million.
Operating EBITDA increased 6% to $448 million, driven by organic growth and productivity. Operating EBITDA margin expanded 40 basis points to 24.6%.
Healthcare And Water Technologies
Healthcare & Water Technologies sales rose 5% to $856 million, with organic growth of 4%. Operating EBITDA increased 4% to $258 million, while margin slipped 30 basis points to 30.1%.
Healthcare Technologies sales reached $473 million, led by double-digit growth in personal protection and biopharma.
Water Technologies sales were $383 million, supported by industrial water and semiconductor demand, partly offset by weakness in the Middle East.
Diversified Industrials And Operations
Diversified Industrials sales rose 3% to $963 million, while operating EBITDA increased 7% to $213 million. Margin expanded 70 basis points to 22.1%.
Industrial Technologies sales reached $538 million, led by aerospace and electric-vehicle battery applications. Building Technologies sales totaled $425 million, driven by construction growth.
DuPont launched about 50 AI-supported sales plays, won roughly 150 opportunities and posted an approximately 30% win rate.
Operational initiatives delivered more than 100 basis points of net productivity improvement and on-time, in-full gains.
Operating cash flow totaled $400 million. Transaction-adjusted free cash flow was $326 million, with 127% conversion. Cash stood at $1.74 billion, while long-term debt was $3.13 billion.
DuPont plans to repurchase $250 million of shares in the third quarter.
Raised 2026 Outlook
The company raised full-year adjusted EPS guidance to $7.17-$7.32 from $7.02-$7.16, compared with the $7.13 estimate. It narrowed sales guidance to $7.160 billion-$7.190 billion from $7.155 billion-$7.215 billion, versus the $7.164 billion estimate.
DuPont expects organic sales growth slightly above 4%, including about 6% growth in the second half, despite currency headwinds.
It also raised the operating EBITDA midpoint by $15 million to about $1.76 billion.
Conference Call
In the earnings conference call, DuPont said that it completed a reverse stock split, aligning its classification to ‘Industrial’ under GICS.
DuPont projects third-quarter adjusted EPS between $1.80 and $1.90, compared to the estimates of $1.93. It expects sales of $1.835 billion, lower than the $1.877 billion estimate.
The company continues to explore M&A opportunities, particularly in water and healthcare, while maintaining a disciplined capital allocation strategy.
DuPont said its operations are optimizing productivity and efficiency through strategic initiatives like the 80/20 rule, aiming for better yield and asset utilization.
DD Price Action: DuPont de Nemours shares were down 0.54% at $140.52 at the time of publication on Tuesday, according to Benzinga Pro data.
Photo by Sundry Photography via Shutterstock
